New Market Study Published: Digestive Remedies in France
The transfer of prescription digestive medicines to the self-medication market continued in France between the end of 2010 and 2011. After the switch of Pantoprazole with a dosage of 20mg per tablet at the end of 2009, Trimebutine 100mg was switched at the end of 2010. As a result, new brands were available within this category: Pantozol Control from Nycomed France, Pantoloc from Novartis Group France and Mopralpro from Bayer Sante Familiale, all of them proton pump inhibitors during 2010,...
View full press release